3[4]Mills J A,Michel B A,Bloch D A,et al.The American College of Rheumatology 1990 criteria for the classification of Henoch-Schnlein purpura[J].Arthritis Rheum,1990,33(8):1114-1121.
4[5]Itazawa T,Adachi Y,Nakabayashi M,et al.Theophylline metabolism in acute asthma with MxA-indicated viral infection[J].Pediatr Int,2006,48(1):54-57.
5[7]Yang Y H,Chuang Y H,Wang L C,et al.The immunobiology of Henoch-Schnlein purpura[J].Autoimmun Rev,2008,7(3):179-184.
6[8]Porter B F,Ambrus A,Storts R W.Immunohistochemical evaluation of MxA protein expression in canine encephalitides[J].Vet Pathol,2006,43(6):981-987.
7[9]Rump J A,Jakschiess D,Walker U,et al.Common variable immunodeficiency (CVID) and MxA-protein expression in blood leucocytes[J].Clin Exp Immunol,1995,101(1):89-93.
8[10]Chieux V,Chehadeh W,Hautecoeur P,et al.Increased levels of antiviral MxA protein in peripheral blood of patients with a chronic disease of unknown etiology[J].J Med Virol,2001,65(2):301-308.
9A vlovic J, et al. Resistance to influenza virus and vesicular stomatitis virus conferred by expression of human MxA protein [J]. J Virol, 1990,64:3370-3375.
10Ordien E,RosmorducO,Peltekian C,et al.Inhibition of hepatitis B virus replication by the interferon-inducible MxA protein [J]. J Virol, 2001,75:2684-2691.
